Answers are grounded in this paper and cite their sources.
Tenosynovial giant cell tumor (TGCT) is a rare, benign neoplasm with locally aggressive potential, characterized by an imbalance between a relatively small neoplastic cell population and an abundant inflammatory microenvironment. Dysregulated CSF1 expression by neoplastic cells promotes the recruitment and expansion of CSF1R-expressing macrophages, creating a tumor ecosystem dependent on CSF1/CSF1R signaling. This biological vulnerability has been translated into targeted therapies, with pexidartinib and vimseltinib demonstrating clinically meaningful tumor responses in patients with unresectable or symptomatic TGCT. However, these responses highlight a distinctive translational challenge: inhibition of a major microenvironmental dependency can produce substantial tumor regression without necessarily eliminating the underlying neoplastic population, which does not express CSF1R. This offers a biological rationale for considering residual disease as potentially enriched in neoplastic cells after macrophage-directed therapy. Here, we provide a state-of-the-art overview of treatment efficacy, resistance mechanisms and the translational trajectory of CSF1/CSF1R targeting in TGCT, from biological rationale to pharmacological optimization and patient-relevant clinical benefit. Particular attention is given to therapeutic escape, which may differ from target resistance mutations observed in other oncogene-driven tumors. We propose a conceptual framework distinguishing pharmacological escape, biological escape and clinical failure, while emphasizing that most proposed compensatory mechanisms remain hypothetical in TGCT. Finally, we discuss the need for dynamic biomarkers, longitudinal tissue analyses and patient-derived translational models to better understand response durability and guide treatment sequencing. Therefore, TGCT represents an informative model for precision oncology directed not only against tumor cells, but also against the tumor microenvironment on which they depend.
No takes yet. Share an insight, caveat, or question.
Ceruso et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: